Cetuximab

Cetuximab · EGFR-Targeted Monoclonal Antibody

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

KRAS wild-type Metastatic Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Non-Small Cell Lung Cancer.

Contraindications

Hypersensitivity to active ingredient or any formulation excipients.

Side Effects & Warnings

Acneiform dermatitis, hypomagnesemia, paronychia, severe infusion reactions.

Drug & Dietary Interactions

Caution with strong CYP3A inhibitors or inducers; review concurrent medications.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.